Person who experienced the adverse event (patient)
Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
126763361 | 12676336 | 1 | I | 20160818 | 20160823 | 20160823 | PER | US-PFIZER INC-2016395141 | PFIZER | 52.00 | YR | M | Y | 0.00000 | 20160823 | MD | US | US |
Drug(s) used by person
Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
126763361 | 12676336 | 1 | PS | GABAPENTIN. | GABAPENTIN | 1 | UNK | U | 20235 | ||||||||||
126763361 | 12676336 | 2 | SS | CYMBALTA | DULOXETINE HYDROCHLORIDE | 1 | Oral | 30 MG, 3X/DAY | U | 0 | 30 | MG | TID | ||||||
126763361 | 12676336 | 3 | SS | CYCLOBENZAPRINE HCL | CYCLOBENZAPRINE HYDROCHLORIDE | 1 | Oral | 10 MG, AS NEEDED (THREE TIMES A DAY) | U | 0 | 10 | MG | TABLET |
Indications of drugs used
no results found |
Outcome of event
no results found |
Reactions reported
Event ID | CASEID | DRUG REC ACT | PT |
---|---|---|---|
126763361 | 12676336 | Drug ineffective |
Reporting Sources (this data is often not reported and may therefore be missing here)
no results found |
Therapies reported
no results found |